Tracking some signals on shares of Editas Medicine (EDIT), we can see that the current 20-day moving average vs price signal is Buy. This is the signal from the 20-day MA which is used to monitor changes in stock price. The current signal strength is Weak and the direction has been noted as Strongest. Taking a longer-term view, we can see that the 100-day moving average verse price signal is Sell. The 100-day MA verse price strength is Weak, and the direction of the signal is Weakest.
Some investors may be lamenting the fact that they have not taken full advantage of the long bull run. There are plenty of pundits that are calling for a sharp stock market decline, but there are also many who believe that the ceiling has been raised and there is much more room for stocks to go higher. Getting into the market at these levels may be holding some investors back from jumping into the fray, and nobody can be sure which way the momentum will swing as we near the end of the year. The next round of company earnings reports should provide some good information about future prospects. Investors will be closely watching to see which sectors are running at full speed and which ones are lagging.
After a recent check, we can see that Editas Medicine (EDIT)’s first resistance level is 27.99. On the flip side, investors are tracking the first support level of 26.4. Investors are often paying close attention to stock price support and resistance levels. The support is simply a level where a stock may see a bounce after it has fallen. If the stock price manages to break through the first support level, the attention may shift to the second level of support. The resistance is the opposite of support. As a stock rises, it may see a retreat once it reaches a certain level of resistance.
Investors typically have the option of following what the professional Wall Street analysts are saying about the stock. Analysts may provide estimates and recommendations on stocks that they cover. At the time of writing, the current analyst rating on the stock is 3.875. This is based on a scale where a 5 would represent a Strong Buy, a 4 would equal a Moderate Buy, 3 a hold, 2 a moderate sell, and a rating of 1 would indicate a Strong Sell.
Investors closely watching shares of Editas Medicine (EDIT) may want to focus in on the current opinion signal for the stock. The opinion signal for the current trading session is 16% Sell. Looking back at the last month, the opinion signal reads 80% Sell. This is the combined signal for the previous month when applying a wide array of studies based on price movement. Investors may also be interested in the direction of the opinion signals. The opinion direction is currently Average. This is a measurement over the past three trading sessions that provides an indication of whether the latest recent price movement is following the signal.
Even though the stock market has been cranking along and touching record highs, there are bound to be some rough patches in the near future. Some investors may actually welcome a pullback in order to scoop up some stocks at a relative discount. Investors who are on top of things are most likely ready to spring when the next big buying opportunity pops up. Being prepared for a buying opportunity can make the process much easier when the time comes. As investors look ahead to the next round of company earnings reports, the focus may gravitate to those companies that have positioned themselves for sustained future growth. Many investors will be closely monitoring which companies outperform by the largest margin after earnings results are released.